Evidence map›Paper›PMID 35751642›Full record

ArticleAPMIS : acta pathologica, microbiologica, et immunologica Scandinavica2022

Biomarkers for iron metabolism among patients hospitalized with community-acquired pneumonia caused by infection with SARS-CoV-2, bacteria, and influenza.

Maria Hein Hegelund, Andreas Glenthøj, Camilla Koch Ryrsø, Christian Ritz, Arnold Matovu Dungu, Adin Sejdic, Karoline Cecilie Knudsen List, Rikke Krogh-Madsen, Birgitte Lindegaard, Jørgen Anders Lindholm Kurtzhals and 1 more

Open access · greenAbstract read
In one paragraph

Article in APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Can iron chelators ameliorate viral infections?Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Maria Hein HegelundDepartment of Pulmonary and Infectious Diseases, Nordsjaellands Hospital, Hillerød, Denmark.
Andreas GlenthøjDepartment of Hematology, Rigshospitalet, Copenhagen, Denmark.
Camilla Koch RyrsøDepartment of Pulmonary and Infectious Diseases, Nordsjaellands Hospital, Hillerød, Denmark.
Christian RitzDepartment of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark.
Arnold Matovu DunguDepartment of Pulmonary and Infectious Diseases, Nordsjaellands Hospital, Hillerød, Denmark.
Adin SejdicDepartment of Pulmonary and Infectious Diseases, Nordsjaellands Hospital, Hillerød, Denmark.
Karoline Cecilie Knudsen ListDepartment of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark.
Rikke Krogh-MadsenCentre for Physical Activity Research, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Birgitte LindegaardDepartment of Pulmonary and Infectious Diseases, Nordsjaellands Hospital, Hillerød, Denmark.
Jørgen Anders Lindholm KurtzhalsDepartment of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark.
Daniel Faurholt-JepsenDepartment of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.
Rigshospitalet · DKNordsjællands Hospital · DKUniversity of Copenhagen · DK

Funding

Copenhagen University Hospital of North ZealandOlga Bryde Nielsen foundationTrygFonden 101390TrygFonden 20045
6 · The paper itself

Abstract

Ferritin, the central iron storage protein, has attracted attention as a biomarker of severe COVID-19. Few studies have investigated regulators of iron metabolism in the context of COVID-19. The aim was to evaluate biomarkers for iron metabolism in the acute phase response to community-acquired pneumonia (CAP) caused by SARS-CoV-2 compared with CAP caused by bacteria or influenza virus in hospitalized patients. A cross-sectional study of 164 patients from the Surviving Pneumonia Cohort recruited between January 8, 2019 and May 26, 2020. Blood samples were collected at admission and analyzed for levels of C-reactive protein (CRP), ferritin, soluble transferrin receptor, erythroferrone, and hepcidin. Median (IQR) hepcidin was higher in SARS-CoV-2 with 143.8 (100.7-180.7) ng/mL compared with bacterial and influenza infection with 78.8 (40.1-125.4) and 53.5 (25.2-125.8) ng/mL, respectively. The median ferritin level was more than 2-fold higher in patients with SARS-CoV-2 compared with the other etiologies (p < 0.001). Patients with SARS-CoV-2 had lower levels of erythroferrone and CRP compared with those infected with bacteria. Higher levels of hepcidin and lower levels of erythroferrone despite lower CRP levels among patients with SARS-CoV-2 compared with those infected with bacteria indicate alterations in iron metabolism in patients with SARS-CoV-2 infection.

Indexed as

Community-Acquired InfectionsCOVID-19Influenza, HumanPneumonia, BacterialPneumonia, ViralBiomarkersC-Reactive ProteinCross-Sectional StudiesFerritinsHepcidinsHumansIronSARS-CoV-2BiomarkersC-Reactive ProteinFerritinsHepcidinsIroncommunity-acquired pneumoniaCOVID-19erythroferroneferritinhepcidiniron metabolism

Identifiers

PMID35751642
PMCPMC9349447
OpenAlexW4283460525

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.